In Situ Dendritic Cell Vaccine for Effective Cancer Immunotherapy-Reference-Cited by-同舟云学术

In Situ Dendritic Cell Vaccine for Effective Cancer Immunotherapy

Published:2019-03-05 Issue:3 Volume:13 Page:3083-3094
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Yang Weijing¹²,Zhu Guizhi²,Wang Sheng²,Yu Guocan²,Yang Zhen²^ORCID,Lin Lisen²,Zhou Zijian²,Liu Yijing²,Dai Yunlu²^ORCID,Zhang Fuwu²,Shen Zheyu²,Liu Yuan²,He Zhimei²,Lau Joseph²,Niu Gang²,Kiesewetter Dale O.²,Hu Shuo¹³,Chen Xiaoyuan²^ORCID

Affiliation:

1. Department of PET Center, Xiangya Hospital, Central South University, Changsha, 410008, China

2. Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, Maryland 20892, United States

3. National Clinical Research Center for Geriatric Disorders (XIANGYA), Xiangya Hospital, Central South University, Changsha, 410008, China

Funder

National Natural Science Foundation of China

National Institute of Biomedical Imaging and Bioengineering

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.8b08346

Reference59 articles.

1. Therapeutic vaccines for cancer: an overview of clinical trials